Yubo International Biotech Limited

YBGJ ·Healthcare, Medical Devices, China
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $8.1K $7.0K $6.4K $18.2K $27.5K $1.4M $1.3K
Accounts Receivable $138.0K $165.0K $79.7K $51.9K $162.0K — —
Inventory $24.0K $37.0K $214.6K $322.2K $164.3K $67.1K —
Total Current Assets $667.5K $682.8K $725.2K $750.0K $1.1M $1.9M $4.0K
Property, Plant & Equipment $43.0K $205.9K $375.2K $616.7K $643.9K $79.2K —
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) $42.1K $50.5K $54.4K $67.7K $38.9K $54.9K —
Total Assets $847.1K $1.5M $1.7M $2.3M $4.6M $2.4M $4.0K
Liabilities
Accounts Payable $1.1M $1.0M — — — $191.0K $342.0K
Total Current Liabilities $2.8M $4.7M $3.4M $2.5M $2.8M $1.3M $1.7M
Long-Term Debt — — — — — — —
Total Liabilities $2.8M $4.8M $3.5M $2.9M $4.7M $1.3M $-484.7K
Stockholders' Equity
Retained Earnings $-7.7M $-6.7M $-4.9M $-3.7M $-2.5M $-943.0K $-29.0M
Total Stockholders' Equity $-2.0M $-3.4M $-1.8M $-565.4K $-131.2K $1.2M $488.7K